Atlas Trials

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

Clinical trial NCT00226915 · COMPLETED

Trial details

NCT number
NCT00226915
Sponsor
Japanese Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Start date
2003-04-01
Primary completion
2012-06-01
Enrollment
637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.